Phase II trial of carboplatin and infusional cyclosporine in platinum-resistant recurrent ovarian cancer Robert J. Morgan Jr.Timothy W. SynoldJames H. Doroshow Original Article 04 June 2004 Pages: 283 - 289
Pharmacokinetic interaction between ketoconazole and imatinib mesylate (Glivec) in healthy subjects Catherine DutreixBin PengMichael Seiberling Original Article 08 May 2004 Pages: 290 - 294
Pharmacokinetically guided dosing of carboplatin in paediatric cancer patients with bilateral nephrectomy Gareth J. VealMartin W. EnglishAlan V. Boddy Original Article 04 May 2004 Pages: 295 - 300
Ubiquitous induction of resistance to platinum drugs in human ovarian, cervical, germ-cell and lung carcinoma tumor cells overexpressing isoforms 1 and 2 of dihydrodiol dehydrogenase Hong Bing DengMahesha AdikariHenry Simpkins Original Article 11 May 2004 Pages: 301 - 307
Clinical and pharmacokinetic study of TNP-470, an angiogenesis inhibitor, in combination with paclitaxel and carboplatin in patients with solid tumors Hai T. TranGeorge R. Blumenschein Jr.Roy S. Herbst Original Article 04 June 2004 Pages: 308 - 314
Ascorbate modulation of H2O2 and camptothecin-induced cell death in Jurkat cells Alain-Théophile SanéAndré M. CantinJ. Richard Wagner Original Article 10 June 2004 Pages: 315 - 321
Involvement of oxidative stress and caspase activation in paclitaxel-induced apoptosis of primary effusion lymphoma cells Yi-Fen WangChang-Yu ChenHorng-Ren Lo Original Article 12 June 2004 Pages: 322 - 330
A phase I trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone in combination with gemcitabine for patients with advanced cancer Yun YenKim MargolinMario Sznol Original Article 18 May 2004 Pages: 331 - 342
Effects of the proteasome inhibitor bortezomib alone and in combination with chemotherapy in the A549 non-small-cell lung cancer cell line Melinda M. MortensonMichael G. SchliemanRichard J. Bold Original Article 12 June 2004 Pages: 343 - 353
The effect of DB-67, a lipophilic camptothecin derivative, on topoisomerase I levels in non-small-cell lung cancer cells Aimee K. BenceCynthia A. MattinglyVal R. Adams Original Article 12 June 2004 Pages: 354 - 360
Systemic BCNU enhances the efficacy of local delivery of a topoisomerase I inhibitor against malignant glioma Phillip B. StormViolette M. RenardJon D. Weingart Original Article 10 June 2004 Pages: 361 - 367
A phase I trial of perillyl alcohol administered four times daily for 14 days out of 28 days Howard H. BaileyGeorge WildingRaymond J. Hohl Original Article 15 June 2004 Pages: 368 - 376
